Clinical Trial Update: The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus Ribavirin [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update studying the effects of oral hypoglycemic agents in patients with chronic hepatitis C who are treated with pegylated int…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Chronic Hepatitis C | Phase 4 | Status: UNKNOWN